Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10179787 Chemokine receptor modulators and uses thereof

Patent 10179787 was granted and assigned to Flx Bio, Inc. on January, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10179787

Date of Patent

January 15, 2019

Patent Application Number

15662861

Date Filed

July 28, 2017

Patent Citations Received

‌

US Patent 12006318 Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof

‌

US Patent 10604526 Chemokine receptor modulators and uses thereof

‌

US Patent 11945785 Pyrazine compounds as inhibitors of FLT3

Patent Primary Examiner

‌

Samantha L Shterengarts

Patent abstract

Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of CCR4 activity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10179787 Chemokine receptor modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API